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Ca2ⴙ regulates a spectrum of cellular processes including many aspects of neuronal function. Ca2ⴙ-sensitive events such as neurite extension and axonal guidance are driven by Ca2ⴙ signals that are precisely
organized in both time and space. These complex cues
result from both Ca2ⴙ influx across the plasma membrane and the mobilization of intracellular Ca2ⴙ stores.
In the present study, using rat cortical neurons, we have
examined the effects of the novel intracellular Ca2ⴙmobilizing messenger nicotinic acid adenine dinucleotide phosphate (NAADP) on neurite length and cytosolic
Ca2ⴙ levels. We show that NAADP potentiates neurite
extension in response to serum and nerve growth factor
and stimulates increases in cytosolic Ca2ⴙ from bafilomycin-sensitive Ca2ⴙ stores. Simultaneous blockade of
inositol trisphosphate and ryanodine receptors abolished the effects of NAADP on neurite length and reduced the magnitude of NAADP-mediated Ca2ⴙ signals.
This is the first report demonstrating functional NAADP
receptors in a mammalian neuron. Interplay between
NAADP receptors and more established intracellular
Ca2ⴙ channels may therefore play important signaling
roles in the nervous system.

Changes in cytosolic Ca2⫹ concentration regulate a whole
host of cellular processes (1). In neurons, Ca2⫹ controls crucial
events such as neurotransmitter release and synaptic plasticity
(2, 3). Ca2⫹ signals are generated by opening of Ca2⫹ channels
located both on the cell surface and the membranes of intracellular Ca2⫹ stores (1). Recent evidence suggests that in addition to inositol trisphosphate (4, 5) and ryanodine (6) receptors, which mediate the release of Ca2⫹ from the
(sarco)endoplasmic reticulum, intracellular Ca2⫹ channels sensitive to nicotinic acid adenine dinucleotide phosphate
(NAADP)1 may also be involved in the control of Ca2⫹ dynamics
(7–9). In the sea urchin egg, in which the effects of NAADP
were first characterized, NAADP targets Ca2⫹ channels with
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biochemical (10) and pharmacological (11) properties distinct
from those of inositol trisphosphate and ryanodine receptors.
In addition, these channels appear to be expressed on lysosome-like acidic organelles (the reserve granules) (12). Thus,
NAADP-induced Ca2⫹ release is inhibited by agents that dissipate proton gradients but is readily demonstrable in the
presence of thapsigargin, an inhibitor of Ca2⫹ pumps on the
endoplasmic reticulum (12). NAADP receptors are also unusual
in that receptors can, under certain conditions, inactivate before activation (13, 14). Despite the propensity of the release
process to inactivate, however, NAADP initiates complex Ca2⫹
signals in a variety of systems (7). This is all the more paradoxical given the inability of NAADP receptors to directly support regenerative Ca2⫹ release through the process of Ca2⫹induced Ca2⫹ release (15). Rather, it appears that activation
of NAADP receptors provides a trigger release of Ca2⫹ that
is then amplified by inositol trisphosphate and ryanodine
receptors (7, 14).
Proper development of the central nervous system requires
the formation of appropriate synaptic contacts between neurons (16). Neurons are capable of extending axons over considerable distances, a process that involves signaling events
within the growth cone in response to a variety of extracellular
cues (16). The underlying signal transduction pathways, however, are not well defined, although Ca2⫹ is likely to play key
roles (17). Both spontaneous entry of Ca2⫹ across the plasma
membrane and Ca2⫹ entry in response to guidance cues such as
cell adhesion molecules are crucial for various aspects of neuronal growth (18). Indeed, both the temporal and spatial organization of the ensuing Ca2⫹ signal are likely an important
determinant of the growth response. In Xenopus spinal neurons, for example, Zheng (19) has demonstrated that imposing
localized elevations of Ca2⫹ causes turning of growth cones,
with the direction dictated by the average global Ca2⫹ concentration. In addition to the well-characterized role of Ca2⫹ influx, the mobilization of intracellular Ca2⫹ stores through activation of both inositol trisphosphate (20, 21) and ryanodine
(22, 23) receptors has also been implicated in the control of
neuronal growth. The role of NAADP in process outgrowth,
however, has yet to be defined.
Although the Ca2⫹ mobilizing properties of NAADP have been
characterized in a variety of cells, corresponding information for
neurons is scant, as is knowledge of the downstream consequences of NAADP receptor activation. We therefore investigated possible functional effects of NAADP in mammalian neurons. Our data show for the first time that NAADP-mediated
Ca2⫹ changes, through the mobilization of acidic Ca2⫹ stores and
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FIG. 1. Lipsomal delivery of Lucifer
yellow into neurons. Confocal scanning
images of Lucifer yellow fluorescence (A
and C, green) and neuron-specific enolase
immunoreactivity (B and D, red) after
perfusion of cultures with liposomes containing 10 M dye (A and B) or control
liposomes containing buffer only (C and
D). Scale bar, 10 m.

FIG. 2. Potentiation of neurite outgrowth by NAADP. A⫺J, representative transmitted light images of neurons cultured in Neurobasal-ATM
medium with 10% (v/v) serum (A and B), B27 supplement ⫹ 20 ng/ml NGF (C and D), B27 supplement ⫹ 1 mM dibutyryl cyclic AMP (E and F),
no additions (G and H), or B27 supplement only (I and J). Cultures were maintained in the absence (A, C, E, G, and I) or presence (B, D, F, H, and
J) of NAADP-containing liposomes (100 M). Scale bar, 20 m.

subsequent amplification by Ca2⫹-induced Ca2⫹ release, are
likely to be important in regulating neurite extension.
EXPERIMENTAL PROCEDURES

Neuronal Cell Culture—Neurons were isolated from the cerebral
cortex of newborn rats (4 – 6 days old) as described previously (24) by
enzymatic digestion using 0.5 mg papain/100 mg tissue. Cells were
maintained at 37 °C in an atmosphere of 95% O2 ⫹ 5% CO2 in Neurobasal-ATM medium alone or with the following additions: (i) 10% (v/v)
fetal calf serum, (ii) B27 supplement, (iii) B27 supplement ⫹ 20 ng/ml
NGF (all from Invitrogen), or (iv) B27 supplement ⫹ 1 mM N6,O2dibutyryl sodium salt 3⬘,5⬘-cyclic AMP (Calbiochem). All culture media
contained 20 mM glutamine, 100 units/ml penicillin, and 100 g/ml
streptomycin (Invitrogen). Cells were used 2 or 48 h after isolation. In

the latter case, glial cell growth was inhibited by addition of the mitotic
inhibitor, cytosine ␤-arabino furanoside (1 M; Sigma). Cells were
treated with liposomes and cell-permeable antagonists in basal medium ⫹ B27 supplement for 30 min before transfer to the appropriate
medium in the continued presence of the drugs.
Liposome Preparation—NAADP (1–100 M), Lucifer yellow (10 M),
or heparin (10 mg/ml) was dissolved in 140 mM KCl and incorporated
into liposomes prepared using egg phosphatidylcholine (Sigma) and
1,2-dioleoyl-sn-glycero-3-ethylphosphocholine (Avanti Polar Lipids) at a
5:1 molar ratio (4 mg lipid/ml aqueous phase) as described previously
(25, 26). Unincorporated constituents were removed by dialysis (Sigma
dialysis sacs; molecular weight cutoff, 12,400) against Neurobasal-ATM
medium (for culture experiments) or Hank’s balanced salt solution (for
Ca2⫹ measurements) (1:600 (v/v); 150 min; solution change every 30
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min). Liposomes were used at a 1:20 (v/v) final dilution.
Immunocytochemistry—Cells that had been treated with control liposomes or Lucifer yellow-filled liposomes (see above) were fixed in
phosphate-buffered saline containing freshly prepared 0.2% (w/v) picric
acid and 4% (v/v) paraformaldehyde (20 min). After sequential incubations (in phosphate-buffered saline) with blocking solution (10% (v/v)
normal horse serum), primary antibody (anti-mouse neuron-specific
enolase IgG; 1:300 dilution; 4 h; Chemicon International), secondary
antibody (biotinylated anti-mouse IgG; 1:50 dilution; 1 h; Vector Laboratories), and fluorophore (Avidin Texas Red; 1:50 dilution; 3 h; Vector
Laboratories), the coverslips were mounted in Citifluor medium (Ted
Pella) for viewing. Lucifer yellow fluorescence and Texas Red fluorescence were captured with a confocal scanning laser microscope (Leica
TCS SP2) using excitation/emission wavelengths of 457/520 and 543/
620 nm, respectively.
Measurement of Neurite Length—Cells were fixed as described above,
and only individual neurons without contacts were used for measurements. The length of the longest neurite (from the cell body to the
growth cone tip) was measured using transmitted light images captured with a Leica confocal microscope. For each treatment, a total of
600 neurites (100 neurites per independent culture) were analyzed.
Measurement of Cytosolic Ca2⫹ Concentration—Cytosolic Ca2⫹ concentration measurements were performed as described previously (27).
Briefly, freshly dissociated neurons (2 h after isolation) were loaded
with the fluorescent Ca2⫹ indicator Fura-2 by incubation of the cells in
Hank’s balanced salt solution supplemented with 3 M Fura-2/AM for
45 min and Hank’s balanced salt solution alone for an additional 15– 60
min (to allow de-esterification of the dye). Coverslips were placed in a
custom-designed bath and transferred to the stage of an inverted epifluorescence microscope equipped with a C & L Instruments fluorometer
system. Cells were perfused at a flow rate of 2.5 ml/min, and Fura-2
fluorescence (excitation wavelength ⫽ 340 and 380 nm, emission wavelength ⫽ 520 nm) of single cells was acquired at a frequency of 1 Hz. The
ratio of the fluorescence signals obtained (340/380 nm) was converted to
Ca2⫹ concentration according to Grynkiewicz et al. (28).
RESULTS AND DISCUSSION

We have previously used the liposome technique to effect
intracellular delivery of various cell impermeant molecules
including NAADP (26, 29). To demonstrate the effectiveness of
the methodology in rat cortical neurons, we first characterized
delivery of the fluorescent marker Lucifer yellow. Cells were
clearly fluorescent when cultures were perfused with liposomes
prepared in the presence of the dye (Fig. 1A). In contrast, little
fluorescence was detected under the same conditions using
liposomes filled with buffer alone (Fig. 1C). Immunocytochemical analysis with a primary antibody raised to neuron-specific
enolase confirmed that imaged cells were neurons (Fig. 1, B
and D).
NAADP has been shown to modulate neurotransmitter release at cholinergic synapses in the buccal ganglion of Aplysia
(30) and the frog neuromuscular junction (26, 29). To explore
possible functional consequences of NAADP-mediated Ca2⫹ increases in rat cortical neurons, we examined the effects of
NAADP on neurite extension. When neurons were cultured in
the presence of serum, NGF, or cyclic AMP, neurite growth was
initiated such that after 2 days in culture, average neurite
length was 40 ⫾ 2, 39 ⫾ 2, and 36 ⫾ 2 m, respectively (n ⫽
600; Fig. 2, A, C, and E). NAADP-containing liposomes (100 M)
dramatically potentiated neurite extension in response to both
serum (Fig. 2B) and NGF (Fig. 2D). The effect of NAADP was
concentration-dependent (Fig. 3A). Rightward shifts in Kolmogorov-Smirnov plots indicate that NAADP stimulated neurite growth in all neurons (Fig. 3, B and C). In contrast,
NAADP did not affect neurite length in medium supplemented
with cell-permeable cyclic AMP (Figs. 2, E and F, and 3A) or

FIG. 3. Effects of NAADP on neurite length. A, effect of NAADP
on neurite outgrowth in cortical neurons cultured for 2 days in medium
supplemented with liposomes containing the indicated concentration of
NAADP and either serum (●), NGF (E), or dibutyryl cyclic AMP (䡺).
Asterisks denote statistical significance (p ⬍ 0.05) compared with

control cultures using a paired t test followed by one-way analysis of
variance. B and C, Kolmogorov-Smirnov distribution-free test of neurite
length distribution in serum (B)- or NGF (C)-containing medium in
either the absence (dotted line) or presence (solid line) of NAADPcontaining liposomes (100 M).
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TABLE I
Effect of inositol trisphosphate and ryanodine receptor antagonists on neurite extension
Neuronal cultures were maintained in the presence of serum or NGF with no further additions (control) or the indicated intracellular Ca2⫹
release channel antagonist. Neurite length was measured after culture in the absence (⫺) or presence (⫹) of NAADP-containing liposomes (100 M)
or elevated K⫹ (6 mM) Antagonist concentrations during liposome preparation were as follows: ryanodine, 100 nM; xestospongin C, 5 M; and
heparin, 10 mg/ml. Stimulation of neuronal growth by NAADP and K⫹ (calculated as fold increase) is shown in parentheses.
Serum

Control
Ryanodine
Xestospongin C
Heparin
Ryanodine ⫹ xestspongin C
Ryanodine ⫹ heparin
a

NGF

⫺NAADP

⫹NAADP

⫹KCl

⫺NAADP

⫹NAADP

⫹KCl

100%
86 ⫾ 1%a
86 ⫾ 2%a
81 ⫾ 1%a
72 ⫾ 2%a
68 ⫾ 2%a

137 ⫾ 2%a (1.4)
124 ⫾ 1%a (1.4)
118 ⫾ 2%a (1.4)
118 ⫾ 1%a (1.5)
77 ⫾ 2%a (1.1)
72 ⫾ 2%a (1.1)

128 ⫾ 1.7%a (1.3)
105 ⫾ 1.9%a (1.2)
108 ⫾ 2% (1.3)
106 ⫾ 2% (1.3)
76 ⫾ 3%a (1.1)
68 ⫾ 2%a (1.0)

100%
91 ⫾ 2%
83 ⫾ 1%a
80 ⫾ 2%a
68 ⫾ 2%a
62 ⫾ 2%a

158 ⫾ 3%a (1.6)
136 ⫾ 1%a (1.5)
113 ⫾ 2%a (1.4)
108 ⫾ 2% (1.4)
73 ⫾ 3%a (1.1)
64 ⫾ 2%a (1.0)

137 ⫾ 2%a (1.4)
122 ⫾ 2%a (1.3)
115 ⫾ 2% (1.4)
109 ⫾ 2% (1.4)
74 ⫾ 2%a (1.1)
62 ⫾ 2%a (1.0)

Statistically significant (p ⬍ 0.05) compared with control cultures (⫺NAADP) using a paired t test followed by one-way analysis of variance.

initiate neurite extension in control basal medium with or
without B27 supplement (Fig. 2, G⫺J). NAADP-induced Ca2⫹
release is therefore not sufficient to induce neurite extension
but appears instead to play a specific modulatory role in serumand NGF-mediated neuronal growth. Liposomal application of
either inositol trisphosphate or cyclic ADP-ribose (100 M) also
potentiated neurite extension (data not shown).
It is noteworthy that in other cells such as pancreatic acinar
cells, NAADP receptor activation results in the recruitment of
inositol trisphosphate and ryanodine receptors through the
process of Ca2⫹-induced Ca2⫹ release (14). Similarly, neurotransmission at the frog neuromuscular junction in response to
NAADP and endoplasmic reticulum-based Ca2⫹-mobilizing
messengers displays marked synergism (26). Such orchestration of the release of intracellular Ca2⫹ stores by NAADP could
underlie the potentiating effects of NAADP on neurite extension reported here. We therefore examined the effects of inositol trisphosphate and ryanodine receptor antagonists on the
stimulation of neurite length by NAADP. Ryanodine, xestospongin C, and heparin caused a modest (⬍20%) inhibition of
neurite length after culture in the presence of serum (Table I).
Stimulation of neuronal growth by NAADP, however, was
largely unaffected by the antagonists (Table I). In contrast, in
the presence of a combination of xestospongin C and ryanodine,
which inhibited neurite extension by 28 ⫾ 2%, stimulation by
NAADP was almost completely abolished (Table I). Thus,
whereas NAADP increased neurite length 1.4-fold in control
experiments, in the presence of both inhibitors, stimulation
was only 1.1-fold. Essentially similar results were obtained in
response to a combination of heparin and ryanodine (Table I).
Potentiation of neurite extension by NAADP in the presence of
NGF was also much more sensitive to simultaneous block of
both inositol trisphosphate and ryanodine receptors than to
inhibition of only one class of channels (Table I). These data
uncover a requirement for Ca2⫹-induced Ca2⫹ release in mediating the effects of NAADP on neuronal growth. Moreover,
there appears to be functional redundancy in the use of inositol
trisphosphate and ryanodine receptors in cortical neurons, as is
the case during fertilization of sea urchin eggs (31, 32) and
glutamate-mediated hyperpolarization of dopaminergic neurons from rat midbrain (33).
To determine whether Ca2⫹ entry through voltage-sensitive
Ca2⫹ channels could affect neuronal growth, we examined the
effect of elevated K⫹ (6 mM) on neurite length. Stimulation of
Ca2⫹ entry potentiated neurite extension 1.3-fold in serumcontaining medium and 1.4-fold in the presence of NGF (Table
I). Higher concentrations of K⫹ (25 mM) were toxic (data not
shown). As with NAADP, the effects of depolarization were only
modestly affected by inositol trisphosphate or ryanodine receptor antagonists when applied alone (Table I). Additionally, only
after simultaneous blockade of the channels were the effects of
K⫹ on neurite length prevented (Table I). Thus, Ca2⫹-induced

FIG. 4. NAADP-mediated Ca2ⴙ release. A, effect of control liposomes
(L control), liposomes containing 100 M NAADP (L NAADP), or depolarization with 25 mM K⫹ on cytosolic Ca2⫹ concentration of freshly dissociated neurons. B–E, similar to the experiment described in A, except that
before stimulation, neurons were treated with 1 M bafilomycin A1 (B) or
100 nM ryanodine ⫹ 5 M xestospongin C (C) for 60 min, Ca2⫹-free
medium (containing 2.5 mM EGTA) for 5 min (D), or thapsigargin (1 M)
for 45 min (E). Data are from single cells in a typical experiment.

Ca2⫹ release likely amplifies the effects of both NAADP and
Ca2⫹ entry through voltage-sensitive Ca2⫹ channels.
Although NAADP has been demonstrated to stimulate Ca2⫹
release from broken rat brain preparations (34), nothing is
known concerning its action in living mammalian neurons. We
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therefore examined the effects of NAADP on cytosolic Ca2⫹
concentration in our neuronal cultures. Perfusion of neurons
with liposomes filled with buffer only had little effect on cytosolic Ca2⫹ concentration (Fig. 4A). Subsequent perfusion with
NAADP-filled liposomes (100 M), however, markedly increased cytolsolic Ca2⫹ by 58 ⫾ 2 nM (n ⫽ 6). Importantly, Ca2⫹
responses to NAADP were abolished by the V-type ATPase
inhibitor, bafilomycin A1 (Fig. 4B; n ⫽ 6). Bafilomycin A1,
however, did not affect Ca2⫹ increases elicited in response to
depolarization of the plasma membrane. Perfusion of cells with
elevated K⫹ (25 mM) increased cytosolic Ca2⫹ concentration by
96 ⫾ 3 nM (n ⫽ 6) and 112 ⫾ 4 nM (n ⫽ 6) in the absence and
presence of bafilomycin, respectively. These experiments show
for the first time that NAADP mediates increases in cytosolic
Ca2⫹ in mammalian neurons and that these Ca2⫹ increases
likely result from mobilization of acidic Ca2⫹ stores.2 The latter
findings concur with recent reports identifying NAADP-sensitive Ca2⫹ stores as reserve granules in sea urchin eggs (12) and
secretory granules in MIN-6 cells (35, 36), both acidic stores of
Ca2⫹. NAADP may also target lysosome-related Ca2⫹ stores in
pancreatic acinar cells (36) and smooth muscle cells (37). At the
cellular level, expression of NAADP receptors in cortical neurons is consistent with our previous autoradiographical analysis of NAADP binding sites in adult rat brain (38).
NAADP-mediated Ca2⫹ signals were significantly inhibited
but not abolished by a combination of xestospongin C and
ryanodine (Fig. 4C). Ca2⫹ increases in response to NAADP
were 58 ⫾ 2 and 39 ⫾ 3 nM in the absence and presence of the
inhibitors, respectively. High K⫹-induced Ca2⫹ increases
(114 ⫾ 5 nM; Fig. 4C), however, were similar to those in control
experiments (96 ⫾ 3 nM; Fig. 4A). Thus, consistent with the
effect of the antagonists on the potentiation of neurite growth
by NAADP (Table I), Ca2⫹ increases stimulated by NAADP are
amplified by inositol trisphosphate and ryanodine receptors.
NAADP-mediated Ca2⫹ increases were readily demonstrable
in the absence of extracellular Ca2⫹ (Fig. 4D) and in the presence of thapsigargin (Fig. 4E); peak Ca2⫹ increases were 46 ⫾
3 and 37 ⫾ 3 nM, respectively (n ⫽ 6).
Our demonstration of NAADP-induced Ca2⫹ mobilization in
individual neurons, together with previous radiotracer flux
studies using brain microsomes (34), and the distinct regional
distribution of NAADP binding sites compared with inositol
trisphosphate and ryanodine receptors (38) strongly suggest
that dedicated Ca2⫹ channels sensitive to NAADP are expressed in the brain. Importantly, we show that their activation modulates a crucial aspect of neuronal growth and that
this effect and part of the generated Ca2⫹ signal is dependent
upon recruitment of endoplasmic reticulum-based Ca2⫹ release
pathways. Cross-talk between intracellular Ca2⫹ channels in
mammalian neurons then appears very similar to that in sea
urchin eggs (39) and smooth muscle cells (40), in which both the
trigger and amplifier components of the NAADP-induced Ca2⫹
signal are readily resolvable. The situation, however, is different from channel “chatter” (7) in pancreatic acinar cells (14). In
these cells, NAADP-mediated Ca2⫹ signals are completely
blocked by antagonists of inositol trisphosphate or ryanodine
receptors, which reflects either a lower density of NAADP
receptors (41) or perhaps a more direct interaction of NAADP
with the ryanodine receptor (42). It is intriguing that although
inositol trisphosphate and ryanodine receptor antagonists have
only modest effects on NAADP-induced Ca2⫹ signals in neurons, they are, in combination, able to effectively block the
2
Prolonged incubation of neurons with bafilomycin caused cell death
(data not shown), precluding its use to probe the role of acidic Ca2⫹
stores in controlling neurite extension.

potentiating effects of NAADP on neurite length. These data
suggest that the NAADP-stimulated trigger Ca2⫹ signal is not
sufficient to mediate the observed functional effects.
Regardless of the exact mode of action of NAADP, the present data support a key role for NAADP in Ca2⫹-dependent
neuronal function. Indeed, NAADP metabolism by brain membranes is stimulated by Ca2⫹, providing a potential mechanism
for the tight control of NAADP-mediated Ca2⫹ signals (43), and
CD38, a candidate enzyme for the synthesis of NAADP (44), is
expressed throughout early development (45).
Acknowledgments—We thank Steve
Mihai Macovei for useful discussion.

Bolsover,

Chi

Li,

and

REFERENCES
1. Berridge, M. J., Lipp, P., and Bootman, M. D. (2000) Nat. Rev. Mol. Cell. Biol.
1, 11–21
2. Miller, R. J. (1991) Prog. Neurobiol. (N. Y.) 37, 255–285
3. Berridge, M. J. (1998) Neuron 21, 13–26
4. Taylor, C. W. (1998) Biochim. Biophys. Acta 1436, 19 –33
5. Patel, S., Joseph, S. K., and Thomas, A. P. (1999) Cell Calcium 25, 247–264
6. Fill, M., and Copello, J. A. (2002) Physiol. Rev. 82, 893–922
7. Patel, S., Churchill, G. C., and Galione, A. (2001) Trends Biochem. Sci. 26,
482– 489
8. Genazzani, A. A., and Billington, R. A. (2002) Trends Pharmacol. Sci. 23,
165–167
9. Lee, H. C. (2003) Curr. Biol. 13, R186 –R188
10. Berridge, G., Dickinson, G., Parrington, J., Galione, A., and Patel, S. (2002)
J. Biol. Chem. 277, 43717– 43723
11. Genazzani, A. A., Mezna, M., Dickey, D. M., Michelangeli, F., Walseth, T. F.,
and Galione, A. (1997) Br. J. Pharmacol. 121, 1489 –1495
12. Churchill, G. C., Okada, Y., Thomas, J. M., Genazzani, A. A., Patel, S., and
Galione, A. (2002) Cell 111, 703–708
13. Aarhus, R., Dickey, D. M., Graeff, R., Gee, K. R., Walseth, T. F., and Lee, H. C.
(1996) J. Biol. Chem. 271, 8513– 8516
14. Cancela, J. M., Churchill, G. C., and Galione, A. (1999) Nature 398, 74 –76
15. Chini, E. N., and Dousa, T. P. (1996) Biochem. J. 316, 709 –711
16. Song, H.-J., and Poo, M. (2004) Nat. Cell Biol. 3, E81–E88
17. Kater, S. B., and Mills, L. R. (1991) J. Neurosci. 11, 891– 899
18. Gomez, T. M., and Spitzer, N. C. (2000) J. Neurobiol. 44, 174 –183
19. Zheng, J. Q. (2000) Nature 403, 89 –93
20. Takei, K., Shin, R. M., Inoue, T., Kato, K., and Mikoshiba, K. (1998) Science
282, 1705–1708
21. Xiang, Y., Li, Y., Zhang, Z., Cui, K., Wang, S., Yuan, X. B., Wu, C. P., Poo,
M. M., and Duan, S. (2002) Nat. Neurosci. 5, 843– 848
22. Bandtlow, C. E., Schmidt, M. F., Hassinger, T. D., Schwab, M. E., and Kater,
S. B. (1993) Science 259, 80 – 83
23. Hong, K., Nishiyama, M., Henley, J., Tessier-Lavigne, M., and Poo, M. (2000)
Nature 403, 93–98
24. Brailoiu, E., Hoard, J., Brailoiu, G. C., Chi, M., Godbole, R., and Dun, N. J.
(2004) Neurosci. Lett. 365, 10 –13
25. Brailoiu, E., and Miyamoto, M. D. (2000) Neuroscience 95, 927–931
26. Brailoiu, E., Patel, S., and Dun, N. J. (2003) Biochem. J. 373, 313–318
27. Filipeanu, C. M., Brailoiu, E., Le Dun, S., and Dun, N. J. (2002) J. Neurochem.
83, 879 – 884
28. Grynkiewicz, G., Poenie, M., and Tsien, R. Y. (1985) J. Biol. Chem. 260,
3440 –3450
29. Brailoiu, E., Miyamoto, M. D., and Dun, N. J. (2001) Mol. Pharmacol. 60,
718 –724
30. Chameau, P., Van de Vrede, Y., Fossier, P., and Baux, G. (2001) Pfluegers
Arch. 443, 289 –296
31. Lee, H. C., Aarhus, R., and Walseth, T. F. (1993) Science 261, 352–355
32. Galione, A., McDougall, A., Busa, W. B., Willmott, N., Gillot, I., and Whitaker,
M. (1993) Science 261, 348 –352
33. Morikawa, H., Khodakhah, K., and Williams, J. T. (2003) J. Neurosci. 23,
149 –157
34. Bak, J., White, P., Timar, G., Missiaen, L., Genazzani, A. A., and Galione, A.
(1999) Curr. Biol. 9, 751–754
35. Mitchell, K. J., Lai, F. A., and Rutter, G. A. (2003) J. Biol. Chem. 278,
11057–11064
36. Yamasaki, M., Masgrau, R., Morgan, A. J., Churchill, G. C., Patel, S., Ashcroft,
S. J. H., and Galione, A. (2004) J. Biol. Chem. 279, 7234 –7240
37. Kinnear, N. P., Boittin, F. X., Thomas, J. M., Galione, A., and Evans, A. M.
(2004) J. Biol. Chem. 279, 54319 –54326
38. Patel, S., Churchill, G. C., Sharp, T., and Galione, A. (2000) J. Biol. Chem. 275,
36495–36497
39. Churchill, G. C., and Galione, A. (2000) J. Biol. Chem. 275, 38687–38692
40. Boittin, F. X., Galione, A., and Evans, A. M. (2003) Circ. Res. 91, 1168 –1175
41. Patel, S. (2004) Biol. Cell 96, 19 –28
42. Gerasimenko, J. V., Maruyama, Y., Yano, K., Dolman, N., Tepikin, A. V.,
Petersen, O. H., and Gerasimenko, O. V. (2003) J. Cell Biol. 163, 271–282
43. Berridge, G., Cramer, R., Galione, A., and Patel, S. (2002) Biochem. J. 365,
295–301
44. Lee, H. C. (2000) Chem. Immunol. 75, 39 –59
45. Ceni, C., Pochon, N., Brun, V., Muller-Steffner, H., Andrieux, A., Grunwald,
D., Schuber, F., De Waard, M., Lund, F., Villaz, M., and Moutin, M. J.
(2002) Biochem. J. 370, 175–183

